These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8307689)

  • 1. Implications of replacing peptide bonds in the COOH-terminal B chain domain of insulin by the psi (CH2-NH) linker.
    Nakagawa SH; Johansen NL; Madsen K; Schwartz TW; Tager HS
    Int J Pept Protein Res; 1993 Dec; 42(6):578-84. PubMed ID: 8307689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of main-chain flexibility and the insulin fold in insulin-receptor interactions.
    Nakagawa SH; Tager HS
    Biochemistry; 1993 Jul; 32(28):7237-43. PubMed ID: 8343513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semisynthetic des-(B27-B30)-insulins with modified B26-tyrosine.
    Lenz V; Gattner HG; Sievert D; Wollmer A; Engels M; Höcker H
    Biol Chem Hoppe Seyler; 1991 Jul; 372(7):495-504. PubMed ID: 1930732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the C-terminus of the insulin B-chain in modulating structural and functional properties of the hormone.
    Leyer S; Gattner HG; Leithäuser M; Brandenburg D; Wollmer A; Höcker H
    Int J Pept Protein Res; 1995 Nov; 46(5):397-407. PubMed ID: 8567184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. Steric and conformational effects.
    Nakagawa SH; Tager HS
    J Biol Chem; 1986 Jun; 261(16):7332-41. PubMed ID: 3519607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
    Záková L; Barth T; Jirácek J; Barthová J; Zórad S
    Biochemistry; 2004 Mar; 43(8):2323-31. PubMed ID: 14979729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the phenylalanine B24 side chain in directing insulin interaction with its receptor. Importance of main chain conformation.
    Mirmira RG; Tager HS
    J Biol Chem; 1989 Apr; 264(11):6349-54. PubMed ID: 2649499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
    Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
    J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of the phenylalanine B25 side chain during insulin-receptor and insulin-insulin interactions.
    Mirmira RG; Tager HS
    Biochemistry; 1991 Aug; 30(33):8222-9. PubMed ID: 1868095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacological activity of the N-terminal dermorphin tetrapeptide analogs with CH2-NH peptide bond isosteres.
    Salvadori S; Guerrini R; Borea PA; Tomatis R
    Int J Pept Protein Res; 1992 Nov; 40(5):437-44. PubMed ID: 1362392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphiceptin and beta-casomorphin-5 analogues containing a reduced peptide bond: selective mu-receptor agonists and a novel mu antagonist, H-Tyr-Pro psi (CH2-NH)Phe-Pro-Gly-OH.
    Delaet NG; Verheyden PM; Tourwe D; Van Binst G; Davis P; Burks TF
    Biopolymers; 1992 Aug; 32(8):957-69. PubMed ID: 1330047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the COOH-terminal B-chain domain in insulin-receptor interactions. Identification of perturbations involving the insulin mainchain.
    Nakagawa SH; Tager HS
    J Biol Chem; 1987 Sep; 262(25):12054-8. PubMed ID: 3305501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semisynthetic insulin analogues modified in positions B24, B25 and B29.
    Svoboda I; Brandenburg D; Barth T; Gattner HG; Jirácek J; Velek J; Bláha I; Ubik K; Kasicka V; Pospísek J
    Biol Chem Hoppe Seyler; 1994 Jun; 375(6):373-8. PubMed ID: 7980868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function relationships of des-(B26-B30)-insulin.
    Spoden M; Gattner HG; Zahn H; Brandenburg D
    Int J Pept Protein Res; 1995; 46(3-4):221-7. PubMed ID: 8537175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of pseudo-peptide analogues of the C-terminal tetrapeptide of gastrin and evaluation of their biological activity on acid secretion.
    Rodriguez M; Bali JP; Magous R; Castro B; Martinez J
    Int J Pept Protein Res; 1986 Mar; 27(3):293-9. PubMed ID: 3011690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A shortened insulin with full in vitro potency.
    Fischer WH; Saunders D; Brandenburg D; Wollmer A; Zahn H
    Biol Chem Hoppe Seyler; 1985 May; 366(5):521-5. PubMed ID: 3890892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of various proposed models of the receptor-bound conformation of H-Tyr-Tic-Phe-OH related delta-opioid antagonists.
    Wilkes BC; Schiller PW
    Biopolymers; 1995; 37(6):391-400. PubMed ID: 8589244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
    Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
    Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations at the dimer, hexamer, and receptor-binding surfaces of insulin independently affect insulin-insulin and insulin-receptor interactions.
    Shoelson SE; Lu ZX; Parlautan L; Lynch CS; Weiss MA
    Biochemistry; 1992 Feb; 31(6):1757-67. PubMed ID: 1737029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An insulin-like growth factor I/insulin hybrid exhibiting high potency for interaction with the type I insulin-like growth factor and insulin receptors of placental plasma membranes.
    Cara JF; Mirmira RG; Nakagawa SH; Tager HS
    J Biol Chem; 1990 Oct; 265(29):17820-5. PubMed ID: 2170397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.